BioMarin Pharmaceutical | BMRN - Cash And Equivalent

Biomarin Pharmaceutical reported $724.53M in Cash and Equivalent for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 114.85M 40M
Acorda Therapeutics ACOR:US USD 37.54M 16.84M
Agios Pharmaceuticals AGIO:US USD 139.26M 16.81M
Alnylam Pharmaceuticals ALNY:US USD 866.39M 206.83M
Amgen AMGN:US USD 9.3B 197M
Bayer BAYN:GR EUR 5.17B 810M
Biogen BIIB:US USD 3.42B 256.3M
Biomarin Pharmaceutical BMRN:US USD 724.53M 36.98M
Bluebird Bio BLUE:US USD 66.48M 15.02M
Gilead Sciences GILD:US USD 7.63B 2.93B
Insmed INSM:US USD 1.07B 659.4M
Intercept Pharmaceuticals ICPT:US USD 50.52M 62.68M
IONIS PHARMACEUT IONS:US USD 276.47M 38.52M
Moderna Inc MRNA:US USD 3.2B 178M
Neurocrine Biosciences NBIX:US USD 262.9M 50.7M
Ptc Therapeutics PTCT:US USD 279.83M 175.41M
Puma Biotechnology PBYI:US USD 76.2M 1.76M
Regeneron Pharmaceuticals REGN:US USD 14.33B 10.84B
Roche Holding ROG:VX 4.99B 676M
Sangamo Biosciences SGMO:US USD 100.44M 5.87M
Sarepta Therapeutics SRPT:US USD 966.78M 71.85M
Seattle Genetics SGEN:US USD 319.94M 42.66M
Ultragenyx Pharmaceutical RARE:US USD 132.94M 258.71M
United Therapeutics UTHR:US USD 961.2M 5.6M
Vertex Pharmaceuticals VRTX:US USD 10.78B 1.61B
YTE INCY:US USD 2.95B 260.8M